1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
CYP2D6 genotype predicts tamoxifen discontinuation and drug response : a secondary analysis of the KARISMA trial
(
- Contribution to journal › Article
- 2012
-
Mark
Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer
(
- Contribution to journal › Article
- 2006
-
Mark
Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR
(
- Contribution to journal › Article